Global Molecular Quality Controls Market to Reach $280.1 Million by 2027
Abstract: - Global Molecular Quality Controls Market to Reach $280. 1 Million by 2027. - Amid the COVID-19 crisis, the global market for Molecular Quality Controls estimated at US$155.
New York, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Molecular Quality Controls Industry" - https://www.reportlinker.com/p06032265/?utm_source=GNW
5 Million in the year 2020, is projected to reach a revised size of US$280.1 Million by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Independent Controls, one of the segments analyzed in the report, is projected to record 8.1% CAGR and reach US$170.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instrument-Specific Controls segment is readjusted to a revised 9.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $46 Million, While China is Forecast to Grow at 8.2% CAGR
- The Molecular Quality Controls market in the U.S. is estimated at US$46 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$48.8 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.
- Select Competitors (Total 33 Featured) -
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher
F. Hoffmann-La Roche Ltd
Helena Biosciences Europe
Maine Molecular Quality Controls, Inc.
Microbiologics, Inc.
Qnostics
Quidel Corporation
Randox Laboratories Ltd.
SeraCare Life Sciences, Inc.
SERO AS
Technopath Clinical Diagnostics
Thermo Fisher Scientific Inc.
ZeptoMetrix Corporation
Read the full report: https://www.reportlinker.com/p06032265/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Molecular Quality
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR
Table 2: World Historic Review for Molecular Quality Controls
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Molecular Quality
Controls by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Independent
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR
Table 5: World Historic Review for Independent Controls by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Independent Controls by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for
Instrument-Specific Controls by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Instrument-Specific Controls
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Instrument-Specific
Controls by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Single-Analyte
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR
Table 11: World Historic Review for Single-Analyte Controls by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Single-Analyte Controls
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Multi-Analyte
Controls by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR
Table 14: World Historic Review for Multi-Analyte Controls by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Multi-Analyte Controls
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Oncology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027
Table 19: World Current & Future Analysis for Genetic Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Genetic Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Genetic Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Infectious
Diseases by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR
Table 23: World Historic Review for Infectious Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Infectious Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 25: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR
Table 26: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 28: USA Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 29: USA Historic Review for Molecular Quality Controls by
Product - Independent Controls and Instrument-Specific Controls
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR
Table 30: USA 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027
Table 31: USA Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 32: USA Historic Review for Molecular Quality Controls by
Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 33: USA 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027
Table 34: USA Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 35: USA Historic Review for Molecular Quality Controls by
Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 36: USA 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027
CANADA
Table 37: Canada Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 38: Canada Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 39: Canada 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027
Table 40: Canada Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 41: Canada Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 42: Canada 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027
Table 43: Canada Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 44: Canada Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 45: Canada 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027
JAPAN
Table 46: Japan Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 47: Japan Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 48: Japan 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027
Table 49: Japan Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 50: Japan Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 51: Japan 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027
Table 52: Japan Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 53: Japan Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 54: Japan 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027
CHINA
Table 55: China Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 56: China Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 57: China 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027
Table 58: China Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 59: China Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 60: China 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027
Table 61: China Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 62: China Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 63: China 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027
EUROPE
Table 64: Europe Current & Future Analysis for Molecular
Quality Controls by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ for Years 2020 through 2027 and % CAGR
Table 65: Europe Historic Review for Molecular Quality Controls
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 66: Europe 15-Year Perspective for Molecular Quality
Controls by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027
Table 67: Europe Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 68: Europe Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 69: Europe 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027
Table 70: Europe Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 71: Europe Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 72: Europe 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027
Table 73: Europe Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 74: Europe Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 75: Europe 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027
FRANCE
Table 76: France Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 77: France Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 78: France 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027
Table 79: France Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 80: France Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 81: France 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027
Table 82: France Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 83: France Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 84: France 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027
GERMANY
Table 85: Germany Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 86: Germany Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 87: Germany 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027
Table 88: Germany Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 89: Germany Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 90: Germany 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027
Table 91: Germany Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 92: Germany Historic Review for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 93: Germany 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027
ITALY
Table 94: Italy Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 95: Italy Historic Review for Molecular Quality Controls
by Product - Independent Controls and Instrument-Specific
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 96: Italy 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027
Table 97: Italy Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 98: Italy Historic Review for Molecular Quality Controls
by Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 99: Italy 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027
Table 100: Italy Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 101: Italy Historic Review for Molecular Quality Controls
by Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 102: Italy 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 103: UK Current & Future Analysis for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 104: UK Historic Review for Molecular Quality Controls by
Product - Independent Controls and Instrument-Specific Controls
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR
Table 105: UK 15-Year Perspective for Molecular Quality
Controls by Product - Percentage Breakdown of Value Sales for
Independent Controls and Instrument-Specific Controls for the
Years 2012, 2020 & 2027
Table 106: UK Current & Future Analysis for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 107: UK Historic Review for Molecular Quality Controls by
Analyte Type - Single-Analyte Controls and Multi-Analyte
Controls Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR
Table 108: UK 15-Year Perspective for Molecular Quality
Controls by Analyte Type - Percentage Breakdown of Value Sales
for Single-Analyte Controls and Multi-Analyte Controls for the
Years 2012, 2020 & 2027
Table 109: UK Current & Future Analysis for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 110: UK Historic Review for Molecular Quality Controls by
Application - Oncology, Genetic Testing, Infectious Diseases
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 111: UK 15-Year Perspective for Molecular Quality
Controls by Application - Percentage Breakdown of Value Sales
for Oncology, Genetic Testing, Infectious Diseases and Other
Applications for the Years 2012, 2020 & 2027
REST OF EUROPE
Table 112: Rest of Europe Current & Future Analysis for
Molecular Quality Controls by Product - Independent Controls
and Instrument-Specific Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 113: Rest of Europe Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 114: Rest of Europe 15-Year Perspective for Molecular
Quality Controls by Product - Percentage Breakdown of Value
Sales for Independent Controls and Instrument-Specific Controls
for the Years 2012, 2020 & 2027
Table 115: Rest of Europe Current & Future Analysis for
Molecular Quality Controls by Analyte Type - Single-Analyte
Controls and Multi-Analyte Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 116: Rest of Europe Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 117: Rest of Europe 15-Year Perspective for Molecular
Quality Controls by Analyte Type - Percentage Breakdown of
Value Sales for Single-Analyte Controls and Multi-Analyte
Controls for the Years 2012, 2020 & 2027
Table 118: Rest of Europe Current & Future Analysis for
Molecular Quality Controls by Application - Oncology, Genetic
Testing, Infectious Diseases and Other Applications -
Independent Analysis of Annual Sales in US$ for the Years 2020
through 2027 and % CAGR
Table 119: Rest of Europe Historic Review for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 120: Rest of Europe 15-Year Perspective for Molecular
Quality Controls by Application - Percentage Breakdown of Value
Sales for Oncology, Genetic Testing, Infectious Diseases and
Other Applications for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Table 121: Asia-Pacific Current & Future Analysis for Molecular
Quality Controls by Product - Independent Controls and
Instrument-Specific Controls - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 122: Asia-Pacific Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 123: Asia-Pacific 15-Year Perspective for Molecular
Quality Controls by Product - Percentage Breakdown of Value
Sales for Independent Controls and Instrument-Specific Controls
for the Years 2012, 2020 & 2027
Table 124: Asia-Pacific Current & Future Analysis for Molecular
Quality Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR
Table 125: Asia-Pacific Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 126: Asia-Pacific 15-Year Perspective for Molecular
Quality Controls by Analyte Type - Percentage Breakdown of
Value Sales for Single-Analyte Controls and Multi-Analyte
Controls for the Years 2012, 2020 & 2027
Table 127: Asia-Pacific Current & Future Analysis for Molecular
Quality Controls by Application - Oncology, Genetic Testing,
Infectious Diseases and Other Applications - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR
Table 128: Asia-Pacific Historic Review for Molecular Quality
Controls by Application - Oncology, Genetic Testing, Infectious
Diseases and Other Applications Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 129: Asia-Pacific 15-Year Perspective for Molecular
Quality Controls by Application - Percentage Breakdown of Value
Sales for Oncology, Genetic Testing, Infectious Diseases and
Other Applications for the Years 2012, 2020 & 2027
REST OF WORLD
Table 130: Rest of World Current & Future Analysis for
Molecular Quality Controls by Product - Independent Controls
and Instrument-Specific Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 131: Rest of World Historic Review for Molecular Quality
Controls by Product - Independent Controls and
Instrument-Specific Controls Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 132: Rest of World 15-Year Perspective for Molecular
Quality Controls by Product - Percentage Breakdown of Value
Sales for Independent Controls and Instrument-Specific Controls
for the Years 2012, 2020 & 2027
Table 133: Rest of World Current & Future Analysis for
Molecular Quality Controls by Analyte Type - Single-Analyte
Controls and Multi-Analyte Controls - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Table 134: Rest of World Historic Review for Molecular Quality
Controls by Analyte Type - Single-Analyte Controls and
Multi-Analyte Controls Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 135: Rest of World 15-Year Perspective for Molecular
Quality Controls by Analyte Type - Percentage Breakdown of
Value Sales for Single-Analyte Controls and Multi-Analyte
Controls for the Years 2012, 2020 & 2027
Table 136: Rest of World Current & Future Analysis for
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032265/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001